The frequency of the specific TP53 R249S mutation in HCC cases exhibits significant geographical variation, strongly correlated with regional levels of AFB1 exposure assessed through dietary surveys or biomarker analysis [29,30,31]. This evidence concerns the gene TP53 and hepatocellular carcinoma.